Skip to content

13F-HR filed by Rosalind Advisors, Inc.

Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-04-25, with 34 holding rows worth $107,020,362.

Accession
0001622627-24-000021
Filed
2024-04-25
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 34 entries on the cover page, a total value of $107,020,362 stated on the cover page (in dollars after the unit check, H1), rows summing to $107,020,362 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MYOMO INC62857J201COM NEW2,447,740$8,004,110dollars as filed
LYRA THERAPEUTICS INC55234L105COM1,144,524$7,118,939dollars as filed
MEDIWOUND LTDM68830112COMMON STOCK485,990$6,925,357dollars as filed
OPTINOSE INC68404V100COM4,541,489$6,630,574dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM2,820,170$6,232,575dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS734,000$6,106,880dollars as filed
CYBIN INC23256X100COM13,960,000$5,772,460dollars as filed
ABIVAX SA-00370M103SPONSORED ADS378,416$5,411,348dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM300,000$5,253,000dollars as filed
DELCATH SYSTEMS INC24661P807COMMON STOCK1,038,828$4,955,209dollars as filed
PROFOUND MED CORP74319B502COM NEW533,333$4,549,330dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS250,000$4,022,500dollars as filed
CLEARSIDE BIOMEDICAL INC185063104COM2,592,593$3,966,667dollars as filed
OUTLOOK THERAPEUTICS INC69012T206COM311,775$3,722,593dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM287,985$3,415,502dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock926,016$3,194,755dollars as filed
Veru Inc92536C103Common Stock4,500,000$3,150,450dollars as filed
UNICYCIVE THERAPEUTICS INC90466Y103CMN1,879,646$2,593,911dollars as filed
CELLECTAR BIOSCIENCES INC15117F807COM621,478$2,473,482dollars as filed
POLYPID LTDM8001Q126COM415,800$1,912,680dollars as filed
INSPIREMD INC45779A846COM686,062$1,626,035dollars as filed
KIORA PHARMACEUTICALS INC49721T309COMMON2,300,000$1,623,800dollars as filed
BEYOND AIR INC08862L103COM903,614$1,572,288dollars as filed
CARA THERAPEUTICS INC140755109COM1,548,893$1,409,493dollars as filed
FORTRESS BIOTECH INC34960Q307COM NEW607,797$1,215,594dollars as filed
SPRUCE BIOSCIENCES INC85209E109COM1,508,419$1,185,466dollars as filed
TALPHERA INC00444T209COM NEW758,966$781,735dollars as filed
BIOFRONTERA INC09077D209COM NEW504,261$776,562dollars as filed
GERON CORP374163103COM200,000$660,000dollars as filed
REZOLUTE INC76200L309COMMON STOCK200,000$510,000dollars as filed
TONIX PHARMACEUTICALS HL890260854COM900,900$167,567dollars as filed
SPDR SER TR78464A870S&P BIOTECH50,000$72,500dollars as filedput
INVESCO QQQ TR46090E953PUT100,000$7,000dollars as filedput
AMYLYX PHARMACEUTICALS INC03237H901COM50,000$0dollars as filedcallValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001622627-24-000021this filing2024-04-25acceptance time not in the bulk data set